A Prescription Checklist for Older Adults in ED A Prescription Checklist for Older Adults in ED
Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 1, 2024 Category: Drugs & Pharmacology Tags: Emergency Medicine Source Type: news
Pessary or Progesterone for Preterm Birth? Advantage Med Pessary or Progesterone for Preterm Birth? Advantage Med
Outcomes were similar with each intervention overall, but the medication appeared to produce better outcomes in women with a cervical length of 25 mm or less.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 29, 2024 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health Source Type: news
Digital Nudges Found to Be Duds in Flu Vax Trial Digital Nudges Found to Be Duds in Flu Vax Trial
Reminders sent via text message or patient portal did not increase rates of influenza vaccination.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 28, 2024 Category: Drugs & Pharmacology Tags: Internal Medicine Source Type: news
Mirikizumab Offers Durable Response Up to 2 Years in UC Mirikizumab Offers Durable Response Up to 2 Years in UC
A long-term maintenance study suggested continuing mirikizumab for 104 weeks is safe and provides durable benefit in patients with active ulcerative colitis.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 27, 2024 Category: Drugs & Pharmacology Tags: Gastroenterology Source Type: news
EMA Approves Ocular Formulation of Bevacizumab EMA Approves Ocular Formulation of Bevacizumab
Europe has approved the use of monoclonal antibody bevacizumab for the treatment of neovascular age-related macular degeneration.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 22, 2024 Category: Drugs & Pharmacology Tags: Ophthalmology Source Type: news
EU Backs First Oral Monotherapy for Adults With PNH EU Backs First Oral Monotherapy for Adults With PNH
The European Medicines Agency has recommended Fabhalta for treating paroxysmal nocturnal hemoglobinuria after reviewing clinical trial results.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 22, 2024 Category: Drugs & Pharmacology Tags: Hematology-Oncology Source Type: news
AI May Help Docs Reply to Patients' Portal Messages AI May Help Docs Reply to Patients' Portal Messages
Easing the burden on providers of responding to each question in a patient portal is a target ripe for solutions.MDedge News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 22, 2024 Category: Drugs & Pharmacology Tags: Internal Medicine Source Type: news
Acne Products With Benzoyl Peroxide Under Scrutiny Acne Products With Benzoyl Peroxide Under Scrutiny
In a citizen ' s petition, Valisure asked the FDA to recall acne products with benzoyl peroxide, stirring debate.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 22, 2024 Category: Drugs & Pharmacology Tags: Dermatology Source Type: news
Novo Nordisk's Once-weekly Basal Insulin Icodec Recommended for Marketing Approval in Europe Novo Nordisk's Once-weekly Basal Insulin Icodec Recommended for Marketing Approval in Europe
Danish drugmaker Novo Nordisk on Thursday said its once-weekly basal insulin icodec for treatment of diabetes in adults had received a recommendation for marketing...Reuters Health Information (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 21, 2024 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology Source Type: news
Secondary Cancers Post CAR T Therapy: A Concern? Secondary Cancers Post CAR T Therapy: A Concern?
An analysis of the FAERS database found the incidence of secondary cancers following CAR T therapy represented 4.3% of all adverse events; however, only 0.1% were secondary T-cell malignancies.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 20, 2024 Category: Drugs & Pharmacology Tags: Hematology-Oncology Source Type: news
EU Lawmakers Vote to Extend Exclusivity Period for New Medicines, Softening Commission Proposal EU Lawmakers Vote to Extend Exclusivity Period for New Medicines, Softening Commission Proposal
Lawmakers in a EU parliamentary committee on Tuesday voted to extend the exclusivity period for new medicines compared to an initial draft, seeking to address concerns...Reuters Health Information (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 19, 2024 Category: Drugs & Pharmacology Tags: Pharmacist Source Type: news
Measles Control So Far in 2024:'Not Off to a Great Start'Measles Control So Far in 2024:'Not Off to a Great Start '
The recent rise in cases across the country is linked to unvaccinated travelers and lower-than-ideal vaccination rates, experts said.WebMD Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 15, 2024 Category: Drugs & Pharmacology Tags: Infectious Diseases Source Type: news
OTC Birth Control Pill: What Clinicians Need to Know OTC Birth Control Pill: What Clinicians Need to Know
While broadly welcomed, the launch of the first nonprescription birth control pill in the United States raises some concerns about patients ' understanding of the dosing schedule and risks when taking the drug on their own.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 14, 2024 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care Source Type: news
Promising Results for Investigational Myasthenia Gravis Drug Promising Results for Investigational Myasthenia Gravis Drug
Treatment with batoclimab resulted in a nearly 60% sustained improvement in daily activities in adult patients with generalized myasthenia gravis.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 13, 2024 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery Source Type: news
Amylyx May Pull FDA-Approved ALS Drug Amylyx May Pull FDA-Approved ALS Drug
Topline results for the ALS drug Relyvrio show that it failed to meet primary or secondary endpoints. The company says it may voluntarily pull the drug from the market.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 8, 2024 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery Source Type: news
